Adherence to local pharmacotherapy management guidelines on prescribing of intravenous cyclophosphamide in vasculitis patients

Abstract

A poster presentation regarding adherence to local pharmacotherapy management guidelines on prescribing of intravenous cyclophosphamide in vasculitis patients. Introduction: If left untreated, vasculitis can result in severe multi-organ damage leading to untimely patients’ death. Intravenous (IV) cyclophosphamide is an essential drug in the pharmacotherapy management of any type of vasculitis resulting in improved patient outcomes. A shared care guideline (SCG) on the prescribing of IV cyclophosphamide is in use at Mater Dei Hospital. This guideline helps clinicians, pharmacists and nurses to work together as a team towards effective patient safety. Aims: • To assess the clinical adherence to the shared care guideline on the pharmacotherapy management of intravenous cyclophosphamide in vasculitis patients. • To identify gaps in adherence against the shared care guideline.